Here, our data provide novel evidence supporting that FA supplement taking as early as possible against the ET1-mediated ETRA activation on hippocampal capillaries is potentially beneficial for memory decline in AD at the earliest stages. The gene discussed is EDNRA; the disease is Alzheimer disease.